Mixed Dyslipidemia

Trials

36 participants · First posted Sep 14, 2015

Active, not recruiting

NCT06497127

A Study in Patients With Mixed Dyslipidemia

145 participants · First posted Jul 11, 2024

Completed

NCT04832971

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

204 participants · First posted Apr 6, 2021

Drugs

View all 57 →

Small Molecule

Approved

Fenofibric acid(Fibricor, Trilipix)

Conditions: Hypertriglyceridemias, Mixed Dyslipidemias +1 more

C₁₇H₁₅ClO₄ · Rx

Dyslipidemia(FunPep)

Mixed Nucleoside

Rx

Organizations

View all 5 →

Saul Centers Inc

United States

United Microelectronics

Gan & Lee Pharmaceuticals Co.,Ltd

China

News

View all 864 →

last year

Junshi Biosciences' Ongericimab Approved in China for Hypercholesterolemia and Mixed Dyslipidemia

3 months ago

Korean Pharmaceutical Companies Launch New Low-Dose Pitavastatin Combination Therapies for Dyslipidemia Management